Detalhe da pesquisa
1.
HK3 stimulates immune cell infiltration to promote glioma deterioration.
Cancer Cell Int
; 23(1): 227, 2023 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37779195
2.
Using integrated analysis from multicentre studies to identify RNA methylation-related lncRNA risk stratification systems for glioma.
Cancer Cell Int
; 23(1): 156, 2023 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37542290
3.
DREAM: a database of experimentally supported protein-coding RNAs and drug associations in human cancer.
Mol Cancer
; 20(1): 148, 2021 11 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34774049
4.
Applications of brain organoids in neurodevelopment and neurological diseases.
J Biomed Sci
; 28(1): 30, 2021 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33888112
5.
Guideline conformity to the Stupp regimen in patients with newly diagnosed glioblastoma multiforme in China.
Future Oncol
; 17(33): 4571-4582, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34519220
6.
NanoRNP Overcomes Tumor Heterogeneity in Cancer Treatment.
Nano Lett
; 19(11): 7662-7672, 2019 11 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31593471
7.
Nanocomposites Inhibit the Formation, Mitigate the Neurotoxicity, and Facilitate the Removal of ß-Amyloid Aggregates in Alzheimer's Disease Mice.
Nano Lett
; 19(2): 674-683, 2019 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30444372
8.
Immunogenomic analysis reveals LGALS1 contributes to the immune heterogeneity and immunosuppression in glioma.
Int J Cancer
; 145(2): 517-530, 2019 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30613962
9.
MiR-134, epigenetically silenced in gliomas, could mitigate the malignant phenotype by targeting KRAS.
Carcinogenesis
; 39(3): 389-396, 2018 03 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29432532
10.
Blocking LINC00152 suppresses glioblastoma malignancy by impairing mesenchymal phenotype through the miR-612/AKT2/NF-κB pathway.
J Neurooncol
; 140(2): 225-236, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30043319
11.
Targeting the Notch1 oncogene by miR-139-5p inhibits glioma metastasis and epithelial-mesenchymal transition (EMT).
BMC Neurol
; 18(1): 133, 2018 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-30170559
12.
Antagomirs Targeting MicroRNA-134 Increase Limk1 Levels After Experimental Seizures in Vitro and in Vivo.
Cell Physiol Biochem
; 43(2): 636-643, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28942448
13.
Overexpression of Transforming Acidic Coiled CoilContaining Protein 3 Reflects Malignant Characteristics and Poor Prognosis of Glioma.
Int J Mol Sci
; 18(3)2017 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28273854
14.
Analysis of expression and prognostic significance of vimentin and the response to temozolomide in glioma patients.
Tumour Biol
; 37(11): 15333-15339, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27704357
15.
The hedgehog antagonist HHIP as a favorable prognosticator in glioblastoma.
Tumour Biol
; 37(3): 3979-86, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26482617
16.
RAB34 was a progression- and prognosis-associated biomarker in gliomas.
Tumour Biol
; 36(3): 1573-8, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25501506
17.
Stable knockdown of LRG1 by RNA interference inhibits growth and promotes apoptosis of glioblastoma cells in vitro and in vivo.
Tumour Biol
; 36(6): 4271-8, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25589464
18.
Whole-genome microRNA expression profiling identifies a 5-microRNA signature as a prognostic biomarker in Chinese patients with primary glioblastoma multiforme.
Cancer
; 119(4): 814-24, 2013 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22990979
19.
Lentivirus-mediated CD/TK fusion gene transfection neural stem cell therapy for C6 glioblastoma.
Tumour Biol
; 34(6): 3731-41, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23828263
20.
A high frequency of MSH6 G268A polymorphism and survival association in glioblastoma.
Int J Neurosci
; 123(2): 114-20, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23057844